Arabic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Effects of Korean Red Ginseng on Semen Parameters in Male Infertility Patients: a Randomized, Placebo-controlled, Double-blind Clinical Study

يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
يتم حفظ الارتباط في الحافظة
الحالةمنجز
الرعاة
Pusan National University Hospital

الكلمات الدالة

نبذة مختصرة

Korean Red ginseng (KRG) has long been applied to various diseases as a health-promoting herbal medicine in Korea. Many clinical studies of ginseng have been performed to elucidate its therapeutic characteristics. KRG has been shown to be effective in many diseases, such as cancers, hypertension, Alzheimer's disease, diabetes, acquired immune deficiency syndrome, and sexual dysfunction. Several studies have indicated effects of ginseng on improving spermatogenesis in animals. The major mechanisms behind these effects were speculated to be anti-oxidant and anti-aging effects, as well as modulation of the hypothalamus-pituitary-testis axis [7 - 10]. However, there have been no controlled human clinical trials to evaluate the effects of KRG on spermatogenesis in patients with male infertility.
Only a small proportion of causes of male infertility are currently curable, including male hypogonadal disorders that can be cured by gonadotropic agents, and obstructive azoospermia that can be corrected by surgery. In addition, evidence-based medicine has revealed that most empirical treatments are ineffective. Similarly, the efficacies of carnitine, anti-estrogens, kallikrein, vitamins C and E, and glutathione have not been confirmed.
Therefore, the investigators investigated the effects of KRG on semen parameters in male infertility patients. This is the first placebo-controlled trial to evaluate the therapeutic effects of KRG in male patients.

تواريخ

آخر التحقق: 07/31/2018
تم الإرسال لأول مرة: 04/23/2014
تم إرسال التسجيل المقدر: 07/28/2014
أول نشر: 07/29/2014
تم إرسال آخر تحديث: 08/26/2018
آخر تحديث تم نشره: 08/28/2018
تاريخ بدء الدراسة الفعلي: 03/31/2011
تاريخ الإنجاز الأساسي المقدر: 01/31/2012
التاريخ المتوقع لانتهاء الدراسة: 11/30/2013

حالة أو مرض

Male Infertility

التدخل / العلاج

Drug: Korean Red Ginseng (KRG)

Procedure: Varicocelectomy

مرحلة

مرحلة 4

مجموعات الذراع

ذراعالتدخل / العلاج
Experimental: V + KRG group (n = 20)
three capsules of KRG (500 mg/dose) daily and varicocelectomy.
Active Comparator: non-V + KRG group
three capsules of KRG (500 mg/dose) daily
Active Comparator: V + P group (n = 20)
placebo capsules and varicocelectomy
Placebo Comparator: non-V + P group
non-V + P group (n = 20) placebo capsules

معايير الأهلية

الأعمار المؤهلة للدراسة 25 Years إلى 25 Years
الأجناس المؤهلة للدراسةMale
يقبل المتطوعين الأصحاءنعم
المعايير

Inclusion Criteria:

- Patients should be males, 25 - 45 years of age, who had complained of infertility for at least 12 months, and had no history of surgical or medical treatments for infertility.

- Increased retrograde flow in the internal spermatic vein with venous diameter > 3 mm during the Valsalva maneuver on scrotal ultrasonography was used as an indicator of varicocele [13].

- Varicocele was graded according to the criteria presented by Lyon et al. [14]: *Grade I, palpable only with the Valsalva maneuver

- Grade II, palpable without the Valsalva maneuver

- Grade III, visible from a distance.

Exclusion Criteria:

- A history of vasectomy or obstructive azoospermia

- Chromosomal abnormalities

- Hypogonadism or pituitary abnormalities

- Anatomical abnormality of the genitals

- Significant hepatopathy (liver enzymes elevated 2 - 3-fold higher than the normal range)

- Renal insufficiency (serum creatinine level > 2.5 mg/dL)

- Medical treatment for infertility during the past 4 weeks.

النتيجة

مقاييس النتائج الأولية

1. Semen parmaters change from baseline to post-treatment [Before treatment, After 14 weeks (12 week treatment and 2 week wash out periond)]

1) sperm concentration, 2) percent motility, 3) sperm viability, and 4) Kruger/strict morphology using World Health Organization (WHO) methodologies (4th edition).

مقاييس النتائج الثانوية

1. Changes in hormonal parameters after treatment [Before treatment, After 14 weeks (12 week treatment and 2 week wash out periond)]

Serum concentrations of FSH and LH were measured using chemiluminescence assays, and serum total testosterone was quantified by radioimmunoassay. The hormonal status of all patients was recorded at the initial screening visit and post-treatment.

انضم إلى صفحتنا على الفيسبوك

قاعدة بيانات الأعشاب الطبية الأكثر اكتمالا التي يدعمها العلم

  • يعمل في 55 لغة
  • العلاجات العشبية مدعومة بالعلم
  • التعرف على الأعشاب بالصورة
  • خريطة GPS تفاعلية - ضع علامة على الأعشاب في الموقع (قريبًا)
  • اقرأ المنشورات العلمية المتعلقة ببحثك
  • البحث عن الأعشاب الطبية من آثارها
  • نظّم اهتماماتك وابقَ على اطلاع دائم بأبحاث الأخبار والتجارب السريرية وبراءات الاختراع

اكتب أحد الأعراض أو المرض واقرأ عن الأعشاب التي قد تساعد ، واكتب عشبًا واطلع على الأمراض والأعراض التي تستخدم ضدها.
* تستند جميع المعلومات إلى البحوث العلمية المنشورة

Google Play badgeApp Store badge